Xiong ZM et al., 2017-05-30: Cell and 3D-skin-model study showing methylene blue was more effective than comparator antioxidants at delaying senescence in human skin fibroblasts from healthy donors and progeria patients, and improved skin viability and wound healing in a reconstructed skin model.
In comparison with other widely used general and mitochondrial-targeting antioxidants, we found that MB was more effective in stimulating skin fibroblast proliferation and delaying cellular senescence.
abstract
Xiong ZM et al., 2017-05-30: Cell and 3D-skin-model study showing methylene blue was more effective than comparator antioxidants at delaying senescence in human skin fibroblasts from healthy donors and progeria patients, and improved skin viability and wound healing in a reconstructed skin model. Study type: in-vitro primary human fibroblasts plus in-vitro reconstructed 3D human skin model. N: fibroblasts from healthy donors and progeria patients (number not stated in abstract). Country: USA. Dose: not stated in abstract (multiple concentrations tested, including 'high concentrations' in the irritation test). Route: topical/culture medium. Comparator: other general and mitochondrial-targeting antioxidants. Funder: NHLBI R01 HL126784, NIA R21 AG043801. Declared conflicts: 'The authors declare that they have no competing interests' – note that the senior author is later disclosed in the 2021 Cells review (Xue et al., doc MTE-19) as founder of Mblue Labs; recorded as neutral disclosure. Senescence delay is in culture, not an organismal lifespan result. Study type: lab.
